NO994659L - Nye pyridinderivater og farmasöytiske preparater inneholdende slike - Google Patents

Nye pyridinderivater og farmasöytiske preparater inneholdende slike

Info

Publication number
NO994659L
NO994659L NO994659A NO994659A NO994659L NO 994659 L NO994659 L NO 994659L NO 994659 A NO994659 A NO 994659A NO 994659 A NO994659 A NO 994659A NO 994659 L NO994659 L NO 994659L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations containing
pyridine derivatives
new pyridine
cycloalkyl
Prior art date
Application number
NO994659A
Other languages
English (en)
Other versions
NO994659D0 (no
Inventor
David Cheshire
David Cladingboel
Simon Hirst
Carol Manners
Michael Stocks
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9701100A external-priority patent/SE9701100D0/xx
Priority claimed from SE9702199A external-priority patent/SE9702199D0/xx
Priority claimed from SE9704403A external-priority patent/SE9704403D0/xx
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO994659D0 publication Critical patent/NO994659D0/no
Publication of NO994659L publication Critical patent/NO994659L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

En forbindelse av formel (I) OH (I) hvor X er O eller S; R1 og R2 er uavhengig hydrogen, Ci_6 alkyl eller C3-e cykloalkyl eller R1 og R2 sammen med karbonatomet som de er bundet til danner en ¿3-0 cykloalkyl- gruppe; R3 er hydrogen og R4 er Ci.6 alkyl eller C3.6 cykloalkyl eller R3 og R4 sammen med karbonatomet som de er bundet til danner en Cs-c cykloalkylgruppe. Forbindelsene ifølge oppfinnelsen er indikert for anvendelse ved behandling eller forebyggelse av allergiske, inflammatoriske, autoimmune, proliferative og hyperproliferative sykdommer.
NO994659A 1997-03-25 1999-09-24 Nye pyridinderivater og farmasöytiske preparater inneholdende slike NO994659L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9701100A SE9701100D0 (sv) 1997-03-25 1997-03-25 Novel compounds
SE9702199A SE9702199D0 (sv) 1997-06-09 1997-06-09 Novel compounds
SE9704403A SE9704403D0 (sv) 1997-11-28 1997-11-28 Novel compounds
PCT/SE1998/000505 WO1998042670A1 (en) 1997-03-25 1998-03-20 Novel pyridine derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO994659D0 NO994659D0 (no) 1999-09-24
NO994659L true NO994659L (no) 1999-11-25

Family

ID=27355863

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994659A NO994659L (no) 1997-03-25 1999-09-24 Nye pyridinderivater og farmasöytiske preparater inneholdende slike

Country Status (17)

Country Link
US (1) US6300352B1 (no)
EP (1) EP0971892A1 (no)
JP (1) JP2001518115A (no)
KR (1) KR20010005646A (no)
CN (1) CN1257481A (no)
AR (1) AR012157A1 (no)
AU (1) AU6530998A (no)
BR (1) BR9808042A (no)
CA (1) CA2284200A1 (no)
EE (1) EE9900426A (no)
ID (1) ID22660A (no)
IL (1) IL131846A0 (no)
NO (1) NO994659L (no)
PL (1) PL335905A1 (no)
SK (1) SK130599A3 (no)
TR (1) TR199902350T2 (no)
WO (1) WO1998042670A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6376524B1 (en) 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
US7338969B2 (en) * 2002-03-08 2008-03-04 Quonova, Llc Modulation of pathogenicity
US7335779B2 (en) * 2002-03-08 2008-02-26 Quonova, Llc Modulation of pathogenicity
US7153889B2 (en) * 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
CA2505427C (en) * 2002-11-12 2012-04-03 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
US20040092521A1 (en) * 2002-11-12 2004-05-13 Altenbach Robert J. Bicyclic-substituted amines as histamine-3 receptor ligands
US20070197492A1 (en) * 2003-05-06 2007-08-23 Aldo Ammendola Modulation of Pathogenicity
EP1778214A4 (en) * 2004-07-27 2010-04-14 Glaxosmithkline Llc NEW BIPHENYL COMPOUNDS AND THEIR USE
US7498049B1 (en) * 2007-01-03 2009-03-03 Shmuel Gonen Topical treatment of acne with combined herbal extracts and minerals
ES2879826T3 (es) 2015-06-15 2021-11-23 Nmd Pharma As Compuestos para su uso en el tratamiento de trastornos neuromusculares
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
SI3921030T1 (sl) * 2019-02-06 2024-03-29 Eli Lilly And Company Derivati 1-((2-(2,2,2-trifluoroetoksi)piridin-4-il)metil)sečnine kot ojačevalci kcnq
CN114989114A (zh) * 2022-06-02 2022-09-02 杭州福斯特电子材料有限公司 一种n-丙烯酰吗啉的合成方法及光固化组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7955287A (en) 1986-10-14 1988-04-21 G.D. Searle & Co. Pyridine derivatives
EP0264114A1 (en) 1986-10-16 1988-04-20 G.D. Searle & Co. Alpha-[(phenylmethoxy)methyl]pyridine-alkanol derivatives
EE9800172A (et) 1995-12-06 1998-12-15 Astra Pharmaceuticals Limited Ühendid

Also Published As

Publication number Publication date
ID22660A (id) 1999-12-02
PL335905A1 (en) 2000-05-22
SK130599A3 (en) 2000-05-16
CA2284200A1 (en) 1998-10-01
AR012157A1 (es) 2000-09-27
CN1257481A (zh) 2000-06-21
US6300352B1 (en) 2001-10-09
EE9900426A (et) 2000-04-17
BR9808042A (pt) 2000-03-08
WO1998042670A1 (en) 1998-10-01
JP2001518115A (ja) 2001-10-09
IL131846A0 (en) 2001-03-19
TR199902350T2 (xx) 2000-04-21
KR20010005646A (ko) 2001-01-15
NO994659D0 (no) 1999-09-24
EP0971892A1 (en) 2000-01-19
AU6530998A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
NO994659L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
DE69416501D1 (de) 2-propylvaleriansäure und 2-propylvalerian-säureamid-derivate und deren verwendung als antikonvulsive mittel
TR199901578T2 (xx) Klaritromisin form 0 kristali
ES8704473A1 (es) Procedimiento para la produccion de derivados de la 13-beta-milbemicina
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
TW427887B (en) Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
PH25859A (en) Composition for treatment of ischemic disorder
DE69505968D1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
HUT75111A (en) Use of pyridyl-,oxadiazole or thiadiazole derivatives for producing pharmaceutical compositions having effect
NO304379B1 (no) 11,21-bisfenyl-19-norpregnan-derivater, anvendelse derav og farmas°ytiske preparater inneholdende slike derivater
CA2013037A1 (en) Aminobenzenesulfonic acid derivative
CA2103590A1 (en) Benzamide derivative
DE69429570D1 (de) Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
AU5162396A (en) Protective agent for organ or tissue
AU7414691A (en) New 3-aminochroman derivatives, process for preparing these and pharmaceutical compositions containing them
NO994764L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende disse
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
ES8300096A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES8600224A1 (es) Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles
AU655869B2 (en) An amphoteric tricyclic compound
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
ES8604843A1 (es) Un metodo para la preparacion de un derivado de acetileno
ES8300776A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
IL95377A0 (en) Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type
ES8505653A1 (es) Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application